Pharmacy - Neuro/Psych pharmacology News & Articles

1 Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain Full Text Health Economics Review, May 17, 2013    Clinical Article

2 Mental Health Treatment Associated with Community-Based Depression Screening: Considerations for Planning Multidisciplinary Collaborative Care Annals of Pharmacotherapy, May 17, 2013    Review Article

3 Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia – open-label trial Acta Neurologica Scandinavica, May 17, 2013    Clinical Article

4 Network analysis reveals patterns of antiepileptic drug use in children with medically intractable epilepsy Epilepsy & Behavior, May 17, 2013    Review Article

5 The impact of prolactin-raising antipsychotics on bone mineral density in patients with schizophrenia: Findings from a longitudinal observational cohort Schizophrenia Research, May 17, 2013    Clinical Article

6 The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis Acta Neurologica Scandinavica, May 17, 2013    Clinical Article

7 Serotonin Kynurenine Hypothesis of Depression: Historical Overview and Recent Developments Current Drug Targets, May 17, 2013    Review Article

8 Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies Epilepsia, May 16, 2013    Clinical Article

9 Pharmacokinetic Considerations for the Use of Levodopa in the Treatment of Parkinson Disease: Focus on Levodopa/Carbidopa/Entacapone for Treatment of Levodopa-Associated Motor Complications Clinical Neuropharmacology, May 16, 2013    Clinical Article

10 Lamotrigine Abolished Aggression in a Patient With Treatment-Resistant Posttraumatic Stress Disorder Clinical Neuropharmacology, May 16, 2013

11 Serotonergic Drugs for Depression and Beyond Current Drug Targets, May 16, 2013    Review Article

12 Designing a Trial to Evaluate Potential Treatments for Apathy in Dementia: The Apathy in Dementia Methylphenidate Trial (ADMET) The American Journal of Geriatric Psychiatry, May 16, 2013    Clinical Article

13 Ibuprofen with or without an antiemetic for acute migraine headaches in adults Cochrane Reviews, May 16, 2013    Evidence Based Medicine    Clinical Article

14 Histone Deacetylase Inhibitors Interact with MDA-7/IL-24 to Kill Primary Human Glioblastoma Cells Molecular Pharmacology, May 16, 2013    Review Article

15 Aripiprazole for Treating Cannabis-Induced Psychotic Symptoms in Ultrahigh-Risk Individuals Clinical Neuropharmacology, May 16, 2013    Clinical Article

16 Low-Dose Manic Switch and High-Dose Antimanic Effect and Extrapyramidal Symptoms by Aripiprazole in a Single Bipolar Patient American Journal of Therapeutics, May 16, 2013

17 Tardive Dyskinesia Caused by Tetrabenazine Clinical Neuropharmacology, May 16, 2013    Clinical Article

18 Curcumin as an Add-On to Antidepressive Treatment: A Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Study Clinical Neuropharmacology, May 16, 2013    Clinical Article

19 Neurological Outcome in Cerebrotendinous Xanthomatosis Treated With Chenodeoxycholic Acid: Early Versus Late Diagnosis Clinical Neuropharmacology, May 16, 2013    Clinical Article

20 Exercise and Sodium Butyrate Transform a Subthreshold Learning Event into Long-Term Memory via a Brain-Derived Neurotrophic factor-Dependent Mechanism Neuropsychopharmacology, May 16, 2013    Review Article

1 Evaluation of a Discharge Medication Service on an Acute Psychiatric Unit Hospital Pharmacy, April 8, 2013

2 Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness BMC Medicine, March 19, 2013    Free full text    Review Article
Exclusive Author Commentary

3 Does levodopa accelerate the pathologic process in Parkinson disease brain Neurology, October 11, 2011

4 Does antidepressant medication use affect persistence with diabetes medicines? Pharmacoepidemiology and Drug Safety, March 6, 2013

5 Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia Archives of Pharmacal Research, April 5, 2013    Free full text

6 Newer antipsychotics and upcoming molecules for schizophrenia European Journal of Clinical Pharmacology, April 3, 2013

7 Clonazepam for the Treatment of Panic Disorder Current Drug Targets, February 12, 2013    Review Article

8 Long-Acting Injectable Antipsychotics and the Development of Postinjection Delirium/Sedation Syndrome (PDSS) Clinical Neuropharmacology, April 5, 2013

9 Influence of CYP1A1/CYP1A2 and AHR polymorphisms on systemic olanzapine exposure Pharmacogenetics and genomics, April 17, 2013    Review Article

10 Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study British Medical Journal, April 23, 2013    Free full text

11 Intravenous topiramate: Safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate Epilepsia, April 22, 2013

12 CYP2D6*2 Polymorphism as a Predictor of Failed Outpatient Tramadol Therapy in Postherpetic Neuralgia Patients American Journal of Therapeutics, April 12, 2013

13 Effect of Topiramate Monotherapy on Height in Newly Diagnosed Children With Epilepsy Pediatric Neurology , April 25, 2013

14 Prolonged febrile seizures, clinical characteristics, and acute management Epilepsia, April 5, 2013

15 Guidance for the Discontinuation or Switching of Antidepressant Therapies in Adults Journal of Pharmacy Practice, March 25, 2013    Clinical Guideline

16 Effects of antipsychotic drugs on the duration of interictal psychotic episodes in patients with epilepsy Epilepsy & Behavior, April 2, 2013

17 Effects of pregabalin on sleep in generalized anxiety disorder International Journal of Neuropsychopharmacology, April 2, 2013    Review Article

18 Treatment for Tobacco Dependence: Effect on Brain Nicotinic Acetylcholine Receptor Density Neuropsychopharmacology, March 28, 2013

19 Reboxetine Treatment for Autistic Spectrum Disorder of Pediatric Patients With Depressive and Inattentive/Hyperactive Symptoms: An Open-Label Trial Clinical Neuropharmacology, April 4, 2013

20 The current and potential impact of genetics and genomics on neuropsychopharmacology European Neuropsychopharmacology, April 4, 2013    Review Article